LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

Home・Aktien・VistaGen Therapeutics Inc

VistaGen Therapeutics Inc

Geschlossen

0.55 -1.79

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.55

Max

0.57

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+76.36% upside

VistaGen Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Feb. 2026, 23:07 UTC

Ergebnisse

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24. Feb. 2026, 23:01 UTC

Ergebnisse

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24. Feb. 2026, 22:59 UTC

Ergebnisse

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24. Feb. 2026, 22:42 UTC

Ergebnisse

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24. Feb. 2026, 22:24 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24. Feb. 2026, 23:48 UTC

Ergebnisse

OCBC's Fourth-Quarter Net Profit Rose on Higher Non-Interest Income

24. Feb. 2026, 23:46 UTC

Market Talk

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24. Feb. 2026, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24. Feb. 2026, 23:30 UTC

Market Talk

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24. Feb. 2026, 23:20 UTC

Market Talk

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24. Feb. 2026, 23:20 UTC

Market Talk

Global Equities Roundup: Market Talk

24. Feb. 2026, 23:16 UTC

Ergebnisse

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24. Feb. 2026, 23:13 UTC

Ergebnisse

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24. Feb. 2026, 23:12 UTC

Ergebnisse

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24. Feb. 2026, 23:10 UTC

Ergebnisse

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24. Feb. 2026, 23:10 UTC

Ergebnisse

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24. Feb. 2026, 23:08 UTC

Ergebnisse

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24. Feb. 2026, 23:07 UTC

Ergebnisse

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24. Feb. 2026, 22:52 UTC

Ergebnisse

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24. Feb. 2026, 22:46 UTC

Ergebnisse

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24. Feb. 2026, 22:31 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Receives New Bid From Paramount -- 3rd Update

24. Feb. 2026, 22:29 UTC

Ergebnisse

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24. Feb. 2026, 22:28 UTC

Ergebnisse

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24. Feb. 2026, 22:27 UTC

Ergebnisse

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24. Feb. 2026, 22:27 UTC

Ergebnisse

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24. Feb. 2026, 22:25 UTC

Ergebnisse

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24. Feb. 2026, 22:24 UTC

Ergebnisse

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24. Feb. 2026, 22:23 UTC

Ergebnisse

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24. Feb. 2026, 22:22 UTC

Ergebnisse

Woolworths Interim Dividend 45 Australian Cents/Share

24. Feb. 2026, 22:22 UTC

Ergebnisse

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

Peer-Vergleich

Kursveränderung

VistaGen Therapeutics Inc Prognose

Kursziel

By TipRanks

76.36% Vorteil

12-Monats-Prognose

Durchschnitt 0.97 USD 76.36%

Hoch 1 USD

Tief 0.9 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für VistaGen Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

5 ratings

Buy

Halten

Sell

Basierend auf 5 Analysten, die in den letzten 3 Monaten Aktienbewertungen für VistaGen Therapeutics Inc – Dist abgegeben haben.

Finanzen

Andere Aktien aus dem Sektor

LLY

Eli Lilly and Co.

1,042.27

↓-1.11%

JNJ

Johnson and Johnson

246.2

↑ +0.25%

ABBV

AbbVie Inc

228.42

↓-0.4%

NVS

Novartis AG

166.68

↑ +1.33%

MRK

Merck & Co Inc.

123.89

↑ +0.15%

VistaGen Therapeutics Inc

Übersicht

Veränderung der Aktienkurses

Empfehlungen

VistaGen Therapeutics Inc Chart

Ähnliche Nachrichten

Peer-Vergleich

VistaGen Therapeutics Inc Prognose

Kursziel

Rating-Konsens

Finanzen

Andere Aktien aus dem Sektor